WALKER KAREN MARIE (Chief Technology Officer) sold 51.5% of their position (24K shares) of KYVERNA THERAPEUTICS, INC. on the open market
Open‑market sale worth $292.8K — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 12/17/2025ACC: 0001193125-25-323332
Officer· Chief Technology Officer
Since Feb 2024
-24K
Net shares
Net seller
$292.8K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
24K acquired · 48K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+24K
Price / share
$4.83
Trade value
$115.91K
% of position
106.0%
12/15/2025
22.64K→46.63K
Common Stock
Direct
Shares
−24K
Price / share
$12.20
Trade value
$292.78K
% of position
51.5%
12/15/2025
46.63K→22.64K
Total
Net shares
+0.00
Net value
-$176.87K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/15/2025 | M · Option Exercise | +24K | $4.83 | $115.91K | 106.0% | 22.64K | 46.63K |
| Common Stock Direct | 12/15/2025 | S · Sale | −24K | $12.20 | $292.78K | 51.5% | 46.63K | 22.64K |
| Total | +0.00 | -$176.87K | ||||||
Derivative Transactions1
Stock option (right to buy)
Direct
Converts to
Common Stock
24K shares
Shares
−24K
Strike price
4.83
Held after
85.86K
Exercisable
—
12/15/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock option (right to buy) Direct | Common Stock24K shares | 12/15/2025 | M · Option Exercise | −24K | 4.83 | — | 85.86K |